跳至主要内容
临床试验/NCT07442071
NCT07442071尚未招募3 期

Impact of Low Dose Epinephrine in the Management of Out-of-hospital Cardiac Arrest on Neurological Outcome: A Multicenter Randomized and Double-blind Trial.

Central Hospital, Nancy, France26 个研究点 分布在 1 个国家目标入组 4,336 人开始时间: 2026年6月1日最近更新:
干预措施

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
4,336
试验地点
26
主要终点
Modified Rankin Scale (mRS) score

研究概览

简要总结

This study will test whether a lower dose of epinephrine (0.5 mg) given during emergency treatment for out-of-hospital cardiac arrest helps more patients survive with good brain function, compared to the standard dose (1 mg). Adults who experience cardiac arrest outside the hospital and are treated by emergency medical teams will be randomly assigned to receive either the low dose or the standard dose of epinephrine. The study will compare survival and neurological outcomes between the two groups over 28 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female, aged ≥18 years. Out-of-hospital cardiac arrest for which resuscitation is decided by the SMUR team.
  • Medical Out-of-hospital cardiac arrest. Affiliated with or beneficiary of a social security plan

排除标准

  • Non-medical Out-of-hospital cardiac arrest (traumatic, drownings, electrocution, asphyxia, overdose, unknown cause).
  • Out-of-hospital cardiac arrest without advanced life support (Do Not Attempt Resuscitation order, body finding, the decision not to attempt advanced life support is at the physician's discretion).
  • Pregnant women, birthing or breastfeeding mothers
  • Adults under legal protection measure (such as guardianship, conservatorship)
  • Individuals deprived of liberty due to judicial or administrative decision

研究组 & 干预措施

Epinephrine 0.5 mg intravenous bolus every 3-5 minutes during Cardio-Pulmonary Resuscitation

Experimental

Epinephrine 0.5 mg intravenous bolus every 3-5 minutes during Cardio-Pulmonary Resuscitation

干预措施: Epinephrine 0.5 mg intravenous bolus (Drug)

Epinephrine 1 mg IV bolus every 3-5 minutes during Cardio-Pulmonary Resuscitation

Active Comparator

Epinephrine 1 mg intravenous bolus every 3-5 minutes during Cardio-Pulmonary Resuscitation

干预措施: Epinephrine 1 mg intravenous bolus (Drug)

结局指标

主要结局

Modified Rankin Scale (mRS) score

时间窗: 28-day

The mRS score is a validated score measuring neurologic outcomes after cardio-pulmonary resuscitation (CPR) : * mRS 0. No symptoms. * mRS 1. No significant disability. Able to perform all usual activities, despite some symptoms. * mRS 2. Slight disability. Independent but unable to perform usual activities (work, sports, leisure). mRS 3. Moderate disability. Requires assistance, but able to walk alone. * mRS 4. Moderately severe disability. Walking assistance and daily living activities not possible. mRS 5. Major disability. Bedridden, incontinent and requires constant nursing care and attention. * mRS 6. Death.

次要结局

  • Vital status(Periprocedural period of cardiopulmonary resuscitation)
  • vital status(28 days post-cardiac arrest)
  • Modified Rankin Scale (mRS) score.(28 days post-cardiac arrest)
  • Return of Spontaneous Circulation (ROSC).(Periprocedural period of cardiopulmonary resuscitation)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

CHOUIHED Tahar

Coordinating Investigator

Central Hospital, Nancy, France

研究点 (26)

Loading locations...

相似试验